Pay in 4 interest-free payments of $22.50 Learn more
Ships within 48 hours · Estimated delivery Jul 26 - Jul 31
Targeting the Transforming Growth Factor-β Signaling in Cancer Therapy
SN-38 is lost into the bile and feces
PubMed PMID: 24598368
Panaxoside Re
CYT387 mesylate - CAS# 1056636-07-7 Catalog No.:M10494-2 Targeting the Transforming Growth Factor-βMomelotinib Mesylate (CYT387 Mesylate) is an ATP competitive inhibitor of JAK1 JAK2 with IC50 of 11 nM 18 nM, appr 10 fold selectivity versus JAK3. Momelotinib inhibits the proliferation of parental Ba F3 cells (Ba F3 wt) stimulated by IL 3 with IC50 of 1400 nM. Furthermore, Momelotinib also causes the inhibition of cell proliferation in cell lines constitutively activated by JAK2 or MPL signaling, including Ba F3 MPLW515L cells, CHRF 288 11 cells and
US$ 125.00
US$ 21.00
US$ 25.00
US$ 32.00
US$ 20.00
US$ 125.00
US$ 150.00
US$ 100.00
US$ 165.00